Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-07-20

Clinical Trial Update: Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight

View source ↗

Summary

Clinical trial update examining insulin resistance during growth hormone therapy for short stature in children with low birthweight.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (Somatropin) (somatropin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Fetal Growth Retardation | Status: UNKNOWN